USANA Health Sciences Inc... (USNA)
USANA Health Sciences Statistics
Share Statistics
USANA Health Sciences has 18.86M shares outstanding. The number of shares has increased by -0.77% in one year.
| Shares Outstanding | 18.86M |
| Shares Change (YoY) | -0.77% |
| Shares Change (QoQ) | -0.81% |
| Owned by Institutions (%) | 56.51% |
| Shares Floating | 11.09M |
| Failed to Deliver (FTD) Shares | 10 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 754.96K, so 3.99% of the outstanding shares have been sold short.
| Short Interest | 754.96K |
| Short % of Shares Out | 3.99% |
| Short % of Float | 6.88% |
| Short Ratio (days to cover) | 2.98 |
Valuation Ratios
The PE ratio is 16.19 and the forward PE ratio is 7.68. USANA Health Sciences's PEG ratio is -0.48.
| PE Ratio | 16.19 |
| Forward PE | 7.68 |
| PS Ratio | 0.8 |
| Forward PS | 0.4 |
| PB Ratio | 1.28 |
| P/FCF Ratio | 13.36 |
| PEG Ratio | -0.48 |
Enterprise Valuation
USANA Health Sciences has an Enterprise Value (EV) of 521.63M.
| EV / Sales | 0.61 |
| EV / EBITDA | 5.28 |
| EV / EBIT | 8.55 |
| EV / FCF | 10.24 |
Financial Position
The company has a current ratio of 2, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2 |
| Quick Ratio | 1.5 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.23 |
| Debt / FCF | 0.45 |
| Interest Coverage | 236.03 |
Financial Efficiency
Return on Equity is 7.9% and Return on Invested Capital is 5.78%.
| Return on Equity | 7.9% |
| Return on Assets | 5.62% |
| Return on Invested Capital | 5.78% |
| Revenue Per Employee | $502.65K |
| Profits Per Employee | $24.72K |
| Employee Count | 1,700 |
| Asset Turnover | 1.14 |
| Inventory Turnover | 2.31 |
Taxes
| Income Tax | 34.32M |
| Effective Tax Rate | 44.95% |
Stock Price Statistics
The stock price has increased by -46.1% in the last 52 weeks. The beta is 1, so USANA Health Sciences's price volatility has been higher than the market average.
| Beta | 1 |
| 52-Week Price Change | -46.1% |
| 50-Day Moving Average | 28.66 |
| 200-Day Moving Average | 35.91 |
| Relative Strength Index (RSI) | 32.34 |
| Average Volume (20 Days) | 213.28K |
Income Statement
In the last 12 months, USANA Health Sciences had revenue of 854.5M and earned 42.03M in profits. Earnings per share was 2.2.
| Revenue | 854.5M |
| Gross Profit | 693.29M |
| Operating Income | 66.32M |
| Net Income | 42.03M |
| EBITDA | 98.86M |
| EBIT | 76.07M |
| Earnings Per Share (EPS) | 2.2 |
Balance Sheet
The company has 181.77M in cash and 23M in debt, giving a net cash position of 158.77M.
| Cash & Cash Equivalents | 181.77M |
| Total Debt | 23M |
| Net Cash | 158.77M |
| Retained Earnings | 478.94M |
| Total Assets | 748.19M |
| Working Capital | 139.56M |
Cash Flow
In the last 12 months, operating cash flow was 60.99M and capital expenditures -10.07M, giving a free cash flow of 50.92M.
| Operating Cash Flow | 60.99M |
| Capital Expenditures | -10.07M |
| Free Cash Flow | 50.92M |
| FCF Per Share | 2.67 |
Margins
Gross margin is 81.13%, with operating and profit margins of 7.76% and 4.92%.
| Gross Margin | 81.13% |
| Operating Margin | 7.76% |
| Pretax Margin | 8.94% |
| Profit Margin | 4.92% |
| EBITDA Margin | 11.57% |
| EBIT Margin | 7.76% |
| FCF Margin | 5.96% |
Dividends & Yields
USNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 6.18% |
| FCF Yield | 7.48% |
Analyst Forecast
The average price target for USNA is $36, which is 51% higher than the current price. The consensus rating is "Hold".
| Price Target | $36 |
| Price Target Difference | 51% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Nov 23, 2016. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 23, 2016 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 4.27 |
| Piotroski F-Score | 6 |